I know I might get killed for saying this but just the quick over view that I had of the 10k did not leave me with a great impression. There were a lot of contradictions to what they have been communicating in their 8k's. I hope a 10 Q clears this all up and soon but it really does appear that this was a cut an paste job with incredibly lousy review. I'm long. Have invested more than most for less shares than most and despite most people feeling bullish on here about the 10k it is obvious that the overall market does not share the same view and I can understand. Attention to detail matters and the lack of effort with an extend release date is concerning to me. Looking forward to Fellers review when he has a moment to see if I missed anything. I really didn't like that they stated they didn't expect any revenue of significance in 2017.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links